Vimarsana
Biggest News Aggregation in the World

Page 11 - Recent Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recent Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recent Updates Today - Breaking & Trending Today

Looking Back And Looking Forward: Castles & Crusades From Troll Lord Games - Vimarsana News

Looking Back And Looking Forward: Castles & Crusades From Troll Lord Games

By Christopher Helton Much like how every fan of Doctor Who has “their” Doctor, so does every fan of fantasy tabletop RPGs have “their” version of

The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment - Vimarsana News

The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment

Dr R. Katie Kelley explains the design and results of the phase 3 CELESTIAL study investigating single-agent cabozantinib for the treatment of advanced hepatocellular carcinoma.

Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC - Vimarsana News

Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC

R. Katie Kelley, MD, comments on the safety and efficacy data from the retrospective analysis of the CELESTIAL study in advanced hepatocellular carcinoma.

Optimal Sequencing in Patients With Advanced HCC - Vimarsana News

Optimal Sequencing in Patients With Advanced HCC

Key opinion leaders discuss the sequencing of systemic therapy options for patients with advanced HCC.

Treatment for Patients Unsuitable for or Refractory to Consolidation Durvalumab - Vimarsana News

Treatment for Patients Unsuitable for or Refractory to Consolidation Durvalumab

Tina Cascone, MD, Ben Levy, MD, and Sandip Patel, MD, offer insights into the treatment approach in patients with unresectable early-stage NSCLC who are unsuitable for consolidation durvalumab or who progress on consolidation durvalumab.